Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
Filed Aug 7, 2012 · 10-Q · 38 days after period end · 0001157523-12-004339
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $19.62M | $16.14M | $14.50M |
| Net Income | $3.74M | $2.28M | $1.07M |
| EPS Diluted | $0.26 | $0.17 | $0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 7, 2012 · 38 d after period end
